Clinical Trials Directory

Trials / Completed

CompletedNCT03538574

Mindfulness Meditation and Insomnia in Alzheimer Disease Caregivers

Mindfulness Meditation and Insomnia in Alzheimer Disease Caregivers: Inflammatory and Biological Aging Mechanisms

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
139 (actual)
Sponsor
University of California, Los Angeles · Academic / Other
Sex
All
Age
45 Years – 95 Years
Healthy volunteers
Not accepted

Summary

Treatment of insomnia in caregivers is needed given that 60% of Alzheimer disease caregivers report sleep complaints, and insomnia may add to the burden of AD caregiving and contribute to morbidity and mortality risk. This is the first intervention trial in AD caregivers to target insomnia and also evaluate two mechanisms of chronic disease risk, inflammation and cellular aging

Detailed description

This randomized controlled trial aims to evaluate the non-inferiority of Mindful Awareness Practices for Insomnia (MAP-I ) vs. Cognitive Behavioral Therapy for Insomnia (CBT-I) on outcomes of insomnia, cellular and genomic markers of inflammation, and cellular aging in older adult AD spousal caregivers with insomnia (N=150) over one-year follow-up. The specific aims of this project are: Primary Aim 1: Determine the effects of MAP-I vs. CBT-I on subjective and objective dimensions of insomnia. Secondary Aim 1: Evaluate the effects of MAP-I vs. CBT-I on cellular and genomic markers of inflammation. Secondary Aim 2: Evaluate the effects of MAP-I vs. CBT-I on markers of cellular aging. Exploratory Aim 1: Explore moderating effects of caregiver stress (Stress and Adversity Inventory, STRAIN, number \& experienced intensity of stress exposure) on insomnia outcomes, and effects of MAP-I vs. CBT-I on caregiver stress, health functioning, chronic medical morbidity and related medication use at follow-up.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCBT-ICBT-I is a behavioral treatment for insomnia
BEHAVIORALMAP-IMAP-I is a mindfulness meditation treatment for insomnia

Timeline

Start date
2018-07-01
Primary completion
2022-09-01
Completion
2022-09-30
First posted
2018-05-29
Last updated
2022-10-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03538574. Inclusion in this directory is not an endorsement.